Skip to main content
TGTX logo

TGTX · Tg Therapeutics, Inc. · Executive Compensation

Track TGTX — free
$61.49 +3.41 (+5.87%) Q2 2026 earnings call transcript
Market Cap
$9.34B
Shares
153.07M
Volume · Oct 30 2.85M Avg daily vol (3M) 1.88M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2021
Executive Total
Michael S. Weiss $42,666,831
Sean A. Power $1,509,360
Fiscal 2020
Executive Total
Michael S. Weiss $32,497,238
Sean A. Power $7,119,841
Fiscal 2019
Executive Total
Michael S. Weiss $12,674,726
Sean A. Power $815,560
Fiscal 2018
Executive Total
Michael S. Weiss $14,298,771
Sean A. Power $1,076,600
Fiscal 2017
Executive Total
Michael S. Weiss $9,926,616
Sean A. Power $1,009,842

Executive changes

Person Change Filed
Sagar Lonial, MD Appointed 2024-06-17
Kenneth Hoberman Appointed 2024-06-17
Daniel Hume Appointed 2024-06-17
Laurence N. Charney Appointed 2024-06-17
Yann Echelard Appointed 2024-06-17
Michael S. Weiss Appointed 2024-06-17

Leadership

Key facts CIK 1001316 CUSIP 88322Q108 13F (30d) 134 filings 122 filers Visit website Investor relations